We are thrilled to share the news that our innovative drug delivery device, VAX-ID® , received recognition as Highly Recommended in the category ‘patient-centric design‘ at this year’s Pharmapack 2023 Awards!
Team IDEVAX is honored with the high praise from the jury for VAX-ID’s patented intradermal drug delivery technology and its ease of use.
🎉 We’re Celebrating Success with Our Partner in Success Voxdale 🎉
None of this was possible without the partnership with Voxdale.
Their dedication and expertise in MedTech to create products that have a positive impact on society and its people is truly inspiring.
IDEVAX extends a heartfelt thank you to the entire team at Voxdale for helping in bringing VAX-ID to life. They make a real difference in the world of drug delivery and patient-centric design.